Breast Growth For Genetic Males

Full Version: Project X (hrt)
You're currently viewing a stripped down version of our content. View the full version with proper formatting.
Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484
Gynecological Herbs

introduction:
Traditionally, a large number of different herbs have been used to affect different aspects of the activity of the female reproductive tract. Historically, there is a legacy of confusion and little agreement even among contemporary authorities about the precise meaning of different designations and classifications of herbs used in gynecology. For a review of author discrepancies see The Phytoestrogen Debate by Peggy Wilbur, and for a historical review of herbs used in gynecological conditions see A Comparative Review of Eclectic Female Regulators by Francis Brinker. Endocrine-like activities of herbs used for gynecological purposes do not necessarily correspond with traditional terminology which is therefore reviewed briefly below. Better general surveys of herbs used gynecologically in modern herbal therapeutics may be found in books by herbalists Amanda McQuade-Crawford and Ruth Trickey.

From the perspective of drug-herb interactions, herbs with identifiable hormone-like activities on the hypothalamic-pituitary-gonadal axis (HPA) are considered in Interactions™, although detailed studies and reports of interactions between pharmaceutical drugs and these agents are not available.
(Brinker F. Brit J Phytotherapy 1997;4,3:123-145; McQuade-Crawford A. 1997; Trickey R. 1998; Wilbur P. Eur J Herbal Med 1996 2.2:20-26, and 1996 2.3:19-26.)

food/herb group affecting drug performance: Oral Contraceptives

mechanism: Phytoestrogenic constituents of foods and medicinal herbs may interact with steroid sex hormone metabolism, and synergize with exogenous steroid hormones in ERT (Estrogen Replacement Therapy), HRT (Hormone Replacement Therapy).

herbal concerns: Despite lack of scientific evidence of adverse interactions, prudence suggests that herbs possessing direct endocrinological effects on the female reproductive tract should be avoided during treatment with ERT (Estrogen Replacement Therapy), HRT (Hormone Replacement Therapy), or GnRH (Gonadotrophic Releasing Hormone) inhibitors.

herbal support: Cimicifuga racemosa (Black Cohosh) has been used to support withdrawal from HRT and ERT and to adjunctively treat symptoms of menopause.

herbs affecting Hypothalamic-Pituitary Axis (HPA):

phytoestrogens: Phytoestrogens may be defined as plant constituents possessing the ability to mimic the biological effects of beta-estradiol in laboratory tests by their ability to bind to the nuclear estrogen receptor, activate transcriptional response and to promote growth of estrogen dependent MCF7 cells in culture. Phytoestrogenic activity is found among the following five naturally occurring chemical compound groupings which are widely distributed among medicinal and food plants:

• Isoflavonoids (e.g., formononetin, daidzein, genistein, coumestrol, biochanin A)
• Sterols (e.g., beta-sitosterol, stigmasterol)
• Saponins (e.g., diosgenin),
• Lignans (e.g., enterolactone),
• Essential oils (Clary sage, Fennel)

Isoflavonoid phytoestrogenic constituents are nutritionally available in plants from the Fabaceae (bean) family, particularly Glycine max (Soybean). Among medicinal plants, the most important phytoestrogenic plant in common therapeutic use is Cimicifuga racemosa (Black Cohosh).

Comprehensive lists of plants containing phytoestrogenic constituents can be found in various sources such as James Duke's Handbook of Phytochemical Constituents of GRAS Herbs and Other Economical Plants or the related database of the Agricultural Research Service - Phytochemical and Ethnobotanical Databases (http://www.ars-grin.gov/duke/) and the NAPRALERT database.
(Duke JA.1994; Miksicek R. Mol Pharmacol, 44(1):37-43, 1993.)

In clinical practice, it has long been known that phytoestrogenic medicinal herbs often have both estrogenic and anti-estrogenic actions. This variability in action remains to be elucidated in terms of potency of phytoestrogenic constituents, balance of agonistic and antagonistic tendencies and compounds, short and long term effects, as well as the problem of different methodological approaches used to identify estrogenicity. The functional endocrinological status of the consumer/patient adds to this complexity, although this is well understood by clinicians experienced in the use of these agents. For example, Cimicifuga racemosa (Black Cohosh) may be used to help correct estrogen dominance in pre-menopausal women yet supports estrogenic activity in post-menopausal women.

Herbalist David Hoffmann has recently reviewed developments in phytoestrogen research and considers that the FDA's National Center for Toxicological Research has identified the importance and need for further research in clarifying the roles of bioavailable estrogenic substances in three respects: estrogen agonism, estrogen antagonism, and endocrine disruption (particularly disruption of the development of secondary sexual characteristics and the reduction of sperm counts). The toxicology approach emphasizes the role of xenoestrogens rather then phytoestrogens, but nutritional phytoestrogens are included within the broad scope of future research and possible regulation. At present, only general conclusions can be made about the role of phytoestrogens which (after Hoffman D.) could be summarized:

1. A number of diverse plant constituents contribute significantly to human estrogen exposure at dietary levels.
2. Nutritionally available estrogenic substances can have a significant role in estrogen metabolism.
3. Biological activity of phytoestrogens extends beyond simple estrogen receptor activity to effects on cellular differentiation, proliferation, angiogenesis, enzyme inhibition, growth factor action and other effects which constitute protective activity against cancer.
4. Dietary incorporation of isoflavone rich foods may contribute to the reduction of risk of cancer; in particular, the majority of studies on soy isoflavones have confirmed significant anti-cancer effects.

aromatase modifiers:Some flavone and isoflavone constituents can inhibit aromatase. Aromatase is a P450 enzyme that catalyzes the formation of estrogens from androgens in many tissues. The activity is greater for flavone constituents rather than the isoflavone constituents, and while this may account for part of the anti-estrogenic activity of some flavonoid phytoestrogens, other herbs are known to reverse low aromatase activity, the most studied being Paeonia lactiflora (White peony). In vitro studies have shown the aromatase action of Paeonia to be due to the monoterpene glycoside, paeoniflorin.
(Chen S, et al. J Steroid Biochem Mol Biol 61,3-6:107-115,1997; Takeuchi T, et al. Am J Chin Med 1991;18:73-78.)

See also the following: Nutrients: Flavonoids, Quercitin and Grapefruit Juice

direct pituitary agents: While Cimicifuga racemosa and soy products can influence pituitary action by peripheral modulation of LH and FSH via estrogenic effects, other herbs act directly upon the pituitary to modify prolactin, FSH and LH levels. The best known example is Vitex agnus-castus (Chasteberry). Animal studies have demonstrated Vitex inhibits prolactin levels in vitro and in vivo by binding to dopamine D2 receptors in the pituitary. Human studies have shown increase in progesterone levels in corpus luteum insufficiency during Vitex administration.

oxytocics: Several plant constituents have been shown to have oxytocic activity, notably caulosaponin and caulophyllosaponin from Caulophyllum thalictroides (Blue Cohosh) which is classified as a traditional emmenagogue. Other oxytocic compounds include sparteine in Cytisus scoparius (Scotch Broom), and quinine from Cinchona species.

commentary: Wild Yam and "Natural Progesterone": There has been some confusion concerning products containing Dioscorea villosa (Mexican Wild Yam) that claim to boost endogenous progesterone levels, or to be a form of "natural progesterone". To add to the confusion, some topical preparations actually contain both Dioscorea extract and pharmaceutical progesterone. The following points should be noted:
The natural steroidal compound diosgenin is in fact estrogenic, not progesteronic.
Diosgenin has been used as a starter compound in the laboratory synthesis of progesterone patented by Marker in the late 1940's known as the Marker Degradation Process.
Homologous metabolic pathways do not exist humans, and diosgenin is therefore not a "precursor" for endogenous progesterone synthesis.
(Brinker F. Brit J Phytotherapy 1997;4,3:123-145; Wilbur P. Eur J Herbal Med 1996 2.2:20-26, and 1996 2.3:19-26.)

terminology: herbs directly affecting the uterus:

Uterine Tonics: Herbs that re-establish normal tone of the uterine muscle and improve overall strength of the organ. Examples: Rubus idaeus (Red raspberry leaf), Angelica sinensis (Dong Quai), Chamaelerium luteum (Helonias, False Unicorn root).
Uterine Spasmolytics: Herbs that reduce the rate and amplitude of uterine contractions. Examples: Viburnum opulus (Cramp bark), Viburnum prunifolium (Black Haw), Ligusticum wallichii (Chuang Xiong).
Uterine Emmenagogues: Traditionally defined as herbs that accelerate delayed menses. More accurately, herbs that stimulate uterine contractions and hence may increase expulsive activity of the uterus.These have also been described as abortifacients. Examples: Ruta graveolens (Rue), Artemisia vulgaris (Mugwort), Mentha pulegium (Pennyroyal).
Uterine Astringents: Herbs that have a vasoconstrictive action on the endometrial circulation. Examples: Achillea millefolium (Yarrow), Alchemilla vulgaris (Lady's mantle), Trillium erectum (Beth root), Capsella bursa-pastoris (Shepherd's Purse).



Herbs

Herbs listed in this section are compiled and edited from electronic databases including Professor Norman Farnsworth's NAPRALERT database at University of Chicago, Illinois, and Dr. James Duke's Phytochemical and Ethnobotanical Databases at the Agricultural Research Service. Textual sources include Michael Moore's Herbal/Medical Contraindications and Francis Brinker's Herb Contraindications and Drug Interactions.
(Moore M. 1995; Brinker F. 1998.)

Plant activities may be based upon widely different assay methods, and may be laboratory, in vitro, in vivo, or human studies. Constituent data is not quantified. Estrogenic constituents are very widely distributed and the following lists are limited to more common medicinal and edible plants. For principal herbs in common therapeutic gynecological use see Summary section of this Herb Group in Interactions™.

Herbs with HPA (Hypothalamic-Pituitary Axis) activty: Oxytocic synergists:

• Asclepias asperula (Immortal)
• Capsella bursa-pastoris (Shepherd's Purse)
• Cinchona spp. (Cinchona bark) *
• Claviceps purpurea (Ergot of Rye) *
• Cytisus scoparius (Scotch Broom)
• Gossypium spp.(Cotton root Bark)
• Leonurus cardiaca (Motherwort)
• Myristica fragrans (Nutmeg)
• Petroselinum crispum (Parsely)
• Senecio aureus (Life Root) *
• Stachys betonica (Wood Betony)
• Glycyrrhiza glabra (Licorice root)
• Paeonia lactiflora (Peony)
• Rehmannia glutinosa (Chinese Foxglove)
• Vitex agnus-castus (Chasteberry)
• Chinese herbal formula: Rehmannia Eight
• Chinese herbal formula: Paeonia and Glycyrrhiza

Herbs with HPA (Hypothalamic-Pituitary Axis) activity: FSH/LH modifiers:

• Cimicifuga racemosa (Black Cohosh)
• Tripterygium wilfordii (Lei Gong Teng) *
• Vitex agnus-castus (Chasteberry)

Herbs with HPA (Hypothalamic-Pituitary Axis) activity: Progestagenics:

• Alchemilla vulgaris (Ladie's mantle)
• Angelica sinensis (Dong Quai)
• Areca catechu (Betel nut)
• Ceanothus americanus (Red Root)
• Vitex agnus-castus (Chasteberry)

Chinese herbal formula: including:

• Angelica sinensis (Dong Quai)
• Astragalus membranaceus (Astragalus)
• Gardenia jasminoides (Zhi zi)
• Leonurus heterophyllus (Chinese Motherwort)
• Panax notoginseng (Pseudoginseng)
• Rubia cordifolia (Madder)
• Scutellaria baicalensis (Baical Skullcap)

Common phytoestrogenic food/herbs containing: Coumestrol

• Brassica spp. (Brussels Sprouts, Cabbage)
• Glycine max (Soybean)
• Medicago sativa (Alfalfa)
• Pisum sativum (Pea)
• Trifolium pratense (Red Clover)
• Vigna radiata (Mungbean)

Common phytoestrogenic food/herbs containing: Biochanin A:

• Baptisia tinctoria (Wild Indigo)
• Medicago sativa (Alfalfa)
• Sophora japonica (Japanese Pagoda Tree)
• Trifolium pratense (Red Clover)
• Vigna radiata (Mungbean)

Common phytoestrogenic food/herbs containing: Daidzein:

• Glycine max (Soybean)
• Phaseolus coccineus (Scarlet Runner Bean)
• Pueraria spp. (Kudzu; Pueraria)
• Trifolium pratense (Red Clover)
• Vigna radiata (Mungbean)

Common phytoestrogenic food/herbs containing: Formononetin:

• Astragalus membranaceus (Astragalus)
• Cimicifuga racemosa (Black Cohosh)
• Glycyrrhiza glabra (Licorice root)
• Medicago sativa (Alfalfa)
• Pueraria spp. (Kudzu; Pueraria)
• Trifolium pratense (Red Clover)
• Vigna radiata (Mungbean)

Common phytoestrogenic food/herbs containing: Genistein:

• Baptisia tinctoria (Wild Indigo)
• Cytisus scoparius (Scotch Broom)
• Glycine max (Soybean)
• Glycyrrhiza glabra (Licorice root)
• Medicago sativa (Alfalfa)
• Pueraria spp. (Kudzu; Pueraria)
• Sophora japonica (Japanese Pagoda Tree)
• Trifolium pratense (Red Clover)
• Vigna radiata (Mungbean)

Common phytoestrogenic food/herbs containing: Beta-Sitosterol:

• Achillea millefolium (Yarrow)
• Allium cepa (Onion)
• Allium sativum (Garlic)
• Aloe vera (Aloe)
• Anethum graveolens (Dill)
• Angelica archangelica (Angelica)
• Angelica sinensis (Dong Quai)
• Arctostaphylos uva-ursi (Bearberry)
• Arnica montana (Arnica)
• Artemisia annua (Sweet Annie)
• Artemisia dracunculus (Tarragon)
• Artemisia vulgaris (Mugwort)
• Asarum canadense (Wild Ginger)
• Asclepias syriaca (Milkweed)
• Aspidosperma quebracho-blanco (Quebracho)
• Astragalus membranaceus (Astragalus)
• Avena sativa (Oats)
• Calendula officinalis (Marigold)
• Capsella bursa-pastoris (Shepherd's Purse)
• Capsicum annuum (Chili Pepper)
• Centaurium erythraea (Centaury)
• Centella asiatica (Gotu Kola)
• Chimaphila umbellata (Pipsissewa)
• Cnicus benedictus (Blessed Thistle)
• Commiphora myrrha (Myrrh)
• Crataegus spp. (Hawthorn)
• Cucurbita pepo (Pumpkin)
• Cytisus scoparius (Scotch Broom)
• Daucus carota (Wild Carrot)
• Echinacea spp. (Echinacea)
• Elettaria cardamomum (Cardamom)
• Eleutherococcus senticosus (Siberian Ginseng)
• Equisetum arvense (Horsetail )
• Fagopyrum esculentum (Buckwheat)
• Foeniculum vulgare (Fennel)
• Fucus vesiculosus (Bladderwrack)
• Glycine max (Soybean)
• Glycyrrhiza glabra (Licorice root)
• Gossypium spp. (Cotton)
• Hordeum vulgare (Barley)
• Humulus lupulus (Hops)
• Hyssopus officinalis (Hyssop)
• Inula helenium (Elecampane)
• Lactuca virosa (Bitter Lettuce)
• Liquidambar orientalis (Oriental Styrax)
• Marrubium vulgare (Horehound)
• Medicago sativa (Alfalfa)
• Melilotus officinalis (Melilot)
• Melissa officinalis (Lemon Balm)
• Mentha spicata (Spearmint)
• Nicotiana tabacum (Tobacco)
• Ocimum basilicum (Basil)
• Oenothera biennis (Evening Primrose)
• Paeonia lactiflora (Peony)
• Panax ginseng (Chinese Ginseng, Korean Ginseng)
• Panax quinquefolius (American Ginseng)
• Pisum sativum (Pea)
• Plantago psyllium (Psyllium seed)
• Ptychopetalum olacoides (Muira Puama)
• Punica granatum (Pomegranate)
• Rehmannia glutinosa (Chinese Foxglove)
• Rosmarinus officinalis (Rosemary)
• Salvia officinalis (Sage)
• Salvia sclarea (Clary Sage)
• Sambucus nigra (Elderflower)
• Sassafras albidum (Sassafras)
• Scutellaria baicalensis (Baikal Skullcap)
• Serenoa repens (Saw Palmetto)
• Smilax spp. (Sarsaparilla)
• Solanum dulcamara (Bitter Nightshade)
• Sophora japonica (Japanese Pagoda Tree)
• Taraxacum officinale ( Dandelion)
• Theobroma cacao (Cacao)
• Tribulus terrestris (Puncture-vine)
• Trifolium pratense (Red Clover)
• Trigonella foenum-graecum (Fenugreek)
• Turnera diffusa (Damiana)
• Urginea maritima (Squill)
• Valeriana officinalis (Valerian)
• Verbascum thapsus (Mullein)
• Viburnum opulus (Crampbark)
• Vinca minor (Periwinkle)
• Viola odorata (Sweet Violet)
• Vitis vinifera (Wine Grape)
• Withania somnifera (Ashwagandha)
• Zea mays (Corn silk)
• Zingiber officinale (Ginger)


http://www.pricklypearjunction.com/inter...ogical.htm
I posted this last month, It's very technical.....but, it just goes to show, not all things are given in NBE. Take for instance this statement:

It is known that DHT can be metabolized to 5alpha-androstane-3beta,17beta-diol (3beta-diol), a hormone that binds to ERbeta but not to AR.


[quote='Lotus' pid='140489' dateline='1420861246']
From an earlier post,


DHT has an estrogenic action,

The existence of this estrogenic DHT metabolite has raised the possibility that estradiol may not be the major estrogen in males [29]. For instance, in the prostate there is a growing body of evidence that 3β-diol, acting through ERβ, may regulate important physiological events.


Recent data have shown that DHT may be converted into 5α-androstane- 3β-17β-diol (3β-diol) in a virtually irreversible reaction. Once considered inactive, 3β-diol is present in high concentrations in the male and indeed has biological activity. However, 3β-diol does not bind to the androgen receptor (AR), but rather to ERα and ERβ, with higher affinity for ERβ. Based upon these findings, we hypothesized that the modulation of AQP9 by DHT could be indirectly mediated by 3β-diol.

---------------------------

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1615873/


Effects of 3-beta-diol, an androgen metabolite with intrinsic estrogen-like effects,

Abstract

Background: Fluid homeostasis is critical for normal function of the male reproductive tract and aquaporins (AQP) play an important role in maintenance of this water and ion balance. Several AQPs have been identified in the male, but their regulation is not fully comprehended. Hormonal regulation of AQPs appears to be dependent on the steroid in the reproductive tract region. AQP9 displays unique hormonal regulation in the efferent ductules and epididymis, as it is regulated by both estrogen and dihydrotestosterone (DHT) in the efferent ductules, but only by DHT in the initial segment epididymis. Recent data have shown that a metabolite of DHT, 5-alpha- androstane-3-beta-17-beta-diol (3-beta-diol), once considered inactive, is also present in high concentrations in the male and indeed has biological activity. 3-beta-diol does not bind to the androgen receptor, but rather to estrogen receptors ER-alpha and ER-beta, with higher affinity for ER-beta. The existence of this estrogenic DHT metabolite has raised the possibility that estradiol may not be the only estrogen to play a major role in the male reproductive system. Considering that both ER-alpha and ER-beta are highly expressed in efferent ductules, we hypothesized that the DHT regulation of AQP9 could be due to the 3-beta-diol metabolite.

Methods: To test this hypothesis, adult male rats were submitted to surgical castration followed by estradiol, DHT or 3-beta-diol replacement. Changes in AQP9 expression in the efferent ductules were investigated by using immunohistochemistry and Western blotting assay.

Results: Data show that, after castration, AQP9 expression was significantly reduced in the efferent ductules. 3- beta-diol injections restored AQP9 expression, similar to DHT and estradiol. The results were confirmed by Western blotting assay.

Conclusion: This is the first evidence that 3-beta-diol has biological activity in the male reproductive tract and that this androgen metabolite has estrogen-like activity in the efferent ductules, whose major function is the reabsorption of luminal fluids.


[Image: attachment.php?aid=8694]


a) It has been shown that 3β-diol may have hormonal activity, not acting through the AR, but rather as a ligand for both ERα and ERβ.

b) 3β-diol has higher affinity for ERβ [31], which is abundant in the efferent ductule epithelium [40].

c) In human testis, the 3β-diol concentration is higher than DHT and estradiol [44,45]. It is reasonable to postulate that high concentrations of this metabolite may enter the lumen of efferent ductules.

d) The existence of this estrogenic DHT metabolite has raised the possibility that estradiol may not be the major estrogen in males [29]. For instance, in the prostate there is a growing body of evidence that 3β-diol, acting through ERβ, may regulate important physiological events [26,28,32,46].

Also noteworthy is the fact that 3β-diol stimulates ERβ induced transcriptional activity equal to the cognate ligand estradiol, and the transcriptional selectivity of 3β-diol for ERβ is much greater than its binding selectivity [30,46]

-----------------------------


Concentrations of aromatase and estradiol in the prostate are low, indicating that estradiol may not be the only estrogenic molecule to play a role in the prostate. It is known that DHT can be metabolized to 5alpha-androstane-3beta,17beta-diol (3beta-diol), a hormone that binds to ERbeta but not to AR. The concentration of 3beta-diol in prostate is much higher than that of estradiol. Based on the high concentration of 3beta-diol and since this metabolite is a physiological ERbeta ligand, we hypothesized that 3beta-diol would be involved in the regulation of ERbeta expression.




[Image: attachment.php?aid=8696]


An endocrine pathway in the prostate, ERbeta, AR, 5alpha-androstane-3beta,17beta-diol, and CYP7B1, regulates prostate growth.
http://www.ncbi.nlm.nih.gov/pubmed/12370428
Wow, well done Lotus. Thanks a lot, POM
Thanks Pom,

It's some pretty crazy stuff huh?, lol.

There's definetly a lot going on inside the male testes, 3-beta diol and 17b HSD (Hydroxysteroid Dehydrogenases) are a huge potential. I find these facts to be very promising. Smile

a) It has been shown that 3β-diol may have hormonal activity, not acting through the AR, but rather as a ligand for both ERα and ERβ.

b) 3β-diol has higher affinity for ERβ [31], which is abundant in the efferent ductule epithelium [40].

c) In human testis, the 3β-diol concentration is higher than DHT and estradiol [44,45]. It is reasonable to postulate that high concentrations of this metabolite may enter the lumen of efferent ductules.

d) The existence of this estrogenic DHT metabolite has raised the possibility that estradiol may not be the major estrogen in males [29]. For instance, in the prostate there is a growing body of evidence that 3β-diol, acting through ERβ, may regulate important physiological events [26,28,32,46].

Also noteworthy is the fact that 3β-diol stimulates ERβ induced transcriptional activity equal to the cognate ligand estradiol, and the transcriptional selectivity of 3β-diol for ERβ is much greater than its binding selectivity [30,46]
So.....does this mean to get more boobs I need to cut my balls off?
Or just up my PM, Reishi and Peony Root?
(23-02-2015, 09:03 PM)elainecd Wrote: [ -> ]So.....does this mean to get more boobs I need to cut my balls off?
Or just up my PM, Reishi and Peony Root?
---------------------------------------------------------
Well elaine, that could be a good solution as long as the Dr. would use them as implants. Smile
It means they may have some benefits for NBE. Rolleyes I mean, why else would estrogen be stored in those things lol. Time to put them to use. Big Grin
(23-02-2015, 09:18 PM)Lotus Wrote: [ -> ]It means they may have some benefits for NBE. Rolleyes I mean, why else would estrogen be stored in those things lol. Time to put them to use. Big Grin

Heck, I just figured it was another way for bio-women to lord it over us. LOL (shutting up now)
This schematic is for those who doubt the existence of E in the man bits, lol.
Surely you can see what I'm getting at, any ideas?, and not the drinking part again please lol. Rolleyes

Yes yes I know, don't call me surely, hahaha. Big Grin
[Image: attachment.php?aid=8944]


[attachment=9515]

Estrogen, Efferent Ductules, and the Epididymis1
http://www.ncbi.nlm.nih.gov/pmc/articles...2_0207.pdf
Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484